A Missing Dimension in Measures of Vaccination Impacts

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Gomes, M Gabriela M ^a   Lipsitch, Marc ^b   Wargo, Andrew R ^c   Kurath, Gael ^d   Rebelo, Carlota ^e   Medley, Graham F ^f   Coutinho, Antonio ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VIRGINIA INSTITUTE OF MARINE SCIENCE   (United States)

^d WESTERN FISHERIES RESEARCH CENTER   (United States)

^e Campo Grande   (Portugal)

^f UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DOSE RESPONSE; HUMAN; IMMUNITY; INTERVENTION STUDY; MATHEMATICAL MODEL; NONHUMAN; POISSON DISTRIBUTION; PREVALENCE; PUBLIC HEALTH; VACCINATION;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; VACCINATION; VACCINES;

EID: 84897455603     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003849     Document Type: Article

References (18)

1. Barskey AE, Cynthia Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, et al. (2012) Mumps Outbreak in Orthodox Jewish Communities in the United States. N Engl J Med 367: 1704-1713.
2. Aaby P, Bukh J, Lisse IM, Smiths AJ, (1984) Overcrowding and intensive exposure as determinants of measles mortality. Am J Epidemiol 120: 49-63.
3. Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, et al. (1971) The Broad Street pump revisited: Response of volunteers to ingested cholera vibrios. Bull N Y Acad Med 47: 1181-1191.
4. Halloran ME, Longini IM Jr, Struchiner CJ (2010) Design and Analysis of Vaccine Studies. New York: Springer.
5. Smith PG, Rodrigues LC, Fine PE, (1984) Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 13: 87-93.
6. Halloran ME, Longini IM Jr, Struchiner CJ, (1996) Estimability and interpretability of vaccine efficacy using frailty mixing models. Am J Epidemiol 144: 83-97.
7. Longini IM Jr, Halloran ME, (1996) A frailty mixture model for estimating vaccine efficacy. Appl Statist 45: 165-173.
8. Struchiner CJ, Halloran ME, (2007) Randomization and baseline transmission in vaccine field trials. Epidemiol Infect 135: 181-194.
9. Furumoto WA, Mickey R, (1967) A mathematical model for the infectivity-dilution curve of tobacco mosaic virus: Theoretical consideration. Virology 32: 216-223.
10. Furumoto WA, Mickey R, (1967) A mathematical model for the infectivity-dilution curve of tobacco mosaic virus: Experimental tests. Virology 32: 224-233.
11. Haas CN, Rose JB, Gerba CP (1999) Quantitative Microbial Risk Assessment. New York: John Wiley & Sons, Inc.
12. Smith DL, Dushoff J, Snow RW, Hay SI, (2005) The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 438: 492-495.
13. Gomes MGM, Aguas R, Lopes JS, Nunes MC, Rebelo C, et al. (2012) How host selection governs tuberculosis reinfection. Proc R Soc B 279: 2473-2478.
14. Keeling MJ, Rohani P (2008) Modeling Infectious Diseases in Humans and Animals. New Jersey: Princeton University Press.
15. Druett HA, (1952) Bacterial invasion. Nature 170: 288.
16. Ben-Ami F, Regoes RR, Ebert D, (2008) A quantitative test of the relationship between parasite dose and infection probability across different host-parasite combinations. Proc R Soc B 275: 853-859.
17. Zwart MP, Hemerik L, Cory JS, de Visser JAGM, Bianchi FJJA, et al. (2011) An experimental text of the independent action hypothesis in virus-insect pathosystems. Proc R Soc B 276: 2233-2242.
18. Dwyer G, Elkinton JS, Buonaccorsi JP, (1997) Host heterogeneity in susceptibility and disease dynamics: Tests of a mathematical model. Am Nat 150: 685-707.